DPDP readiness for healthtech platforms in India

Health data is a stethoscope with a memory, and it rarely forgets politely.

What to review

Healthtech platforms usually touch more than appointment slots and email addresses. A telemedicine product may handle symptoms, prescriptions, lab reports, diagnostic images, wearable readings, insurance details, emergency contacts, doctor notes, payment records and support chats. Under the DPDP Act, the first readiness question is not whether the product is medical enough. It is whether digital personal data is being processed for a clear lawful purpose, with responsibilities that can be evidenced.

Start by separating the platform's roles. A healthtech company may act as a Data Fiduciary when it decides why patient data is collected, a Data Processor when it operates only on a hospital's instructions, and a vendor manager when cloud, analytics, ticketing or communications tools process data on its behalf. The same product can involve all three positions, so contracts and product controls should match the actual workflow.

The review should also account for the wider health data environment. ABDM materials emphasise privacy by design for digital health records and ecosystem participants. Even where a private platform is not fully integrated with ABDM, health-sector expectations make weak consent flows, unclear sharing and casual retention difficult to defend. Product, legal and security teams should treat health data as high-impact operational data and document decisions accordingly.

A useful readiness file should be understandable to engineers and clinicians, not only lawyers. It should explain which data is necessary for care delivery, which data supports business operations, which data is optional, and which data should never be collected unless a senior owner approves the use case.

Implementation steps

1. Map every health data flow from collection to deletion, including patient onboarding, doctor access, lab integrations, pharmacy fulfilment, support, analytics, billing and backups.
2. Identify the purpose for each processing activity and check whether the notice explains that purpose in language patients can understand before data is collected.
3. Test consent and withdrawal journeys for teleconsultations, record sharing, wellness tracking, marketing, research, product analytics and third-party integrations.
4. Classify vendors by role and data access. Review cloud hosting, electronic medical record systems, payment gateways, messaging providers, diagnostic partners, AI tools and customer support platforms.
5. Put processor instructions in writing, including permitted use, confidentiality, security controls, breach support, sub-processor approval, return, deletion and audit evidence.
6. Restrict role-based access for clinical staff, support teams and contractors. Sensitive screens should have need-based access, logging and prompt removal when a user changes role.
7. Build a breach playbook that connects security triage with privacy assessment, patient communication, vendor escalation and evidence preservation.
8. Define retention rules for medical records, account data, logs, prescriptions, support tickets and derived analytics. Do not let indefinite backups become the default answer.

Healthtech teams should add one product-level control: a release review for new data fields. Before a feature captures a symptom, diagnosis, medication history or wearable metric, the review should record purpose, user-facing notice text, storage location, vendor access, retention and deletion behaviour. This keeps privacy work close to the product decision instead of turning it into a late legal clean-up.

Common mistakes

• Treating health data as ordinary account data because the DPDP Act does not use a separate sensitive-data category.
• Letting doctors, support teams and operations users share broad workspace access without clinical need or audit logs.
• Adding analytics, AI or messaging tools before confirming what patient data leaves the core platform.

How DataNuance can help

DataNuance helps Indian healthtech teams turn DPDP readiness into working controls. We can map patient-data flows, review notices and consent journeys, test vendor and processor arrangements, and build a release checklist for health data features. For help preparing a healthtech DPDP readiness plan, speak with DataNuance's privacy advisory team.

FAQs

Does the DPDP Act apply to healthtech platforms in India?

Yes, where the platform processes digital personal data in India or offers goods or services to people in India. Patient, doctor, billing, support and device data can all fall within the review.

Is patient consent always the only basis for processing?

Not always. The correct basis depends on the activity and facts, but consent journeys remain central for many healthtech uses, especially record sharing, optional wellness features, marketing and integrations.

What should be checked before using a health data vendor?

Check the vendor role, data fields, security controls, sub-processors, breach support, deletion duties, own-use restrictions and whether the contract records clear processing instructions.

Should healthtech platforms keep separate DPDP evidence?

Yes. Keep a living file for notices, consent tests, vendor reviews, access controls, breach drills, retention decisions and product-release reviews involving health data.